AR053708A1 - A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT - Google Patents

A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT

Info

Publication number
AR053708A1
AR053708A1 ARP060101345A AR053708A1 AR 053708 A1 AR053708 A1 AR 053708A1 AR P060101345 A ARP060101345 A AR P060101345A AR 053708 A1 AR053708 A1 AR 053708A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
composition used
wound treatment
wounds
polysaccharide
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Maria Ciancia
Alberto Saul Cerezo
Original Assignee
Consejo Nac Invest Cient Tec
Mogullansky Alberto Luis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nac Invest Cient Tec, Mogullansky Alberto Luis filed Critical Consejo Nac Invest Cient Tec
Priority to ARP060101345 priority Critical patent/AR053708A1/en
Publication of AR053708A1 publication Critical patent/AR053708A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion farmacéutica utilizable en el tratamiento de heridas, que comprende al menos un polisacárido, sulfatado y donde el o los polisacáridos se encuentran como solido, en forma de polvo, escamas o planchas obtenidas por un proceso de liofilizacion. En particular, la presente se refiere al uso de uno o más polisacáridos sulfatados, como solido en forma de planchas obtenidas por liofilizacion, en la curacion de heridas de seres humanos y animales.A pharmaceutical composition usable in the treatment of wounds, comprising at least one polysaccharide, sulfated and where the polysaccharide (s) are found as solid, in the form of powder, flakes or plates obtained by a lyophilization process. In particular, this refers to the use of one or more sulfated polysaccharides, as solid in the form of plates obtained by lyophilization, in the healing of wounds of humans and animals.

ARP060101345 2006-04-05 2006-04-05 A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT AR053708A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP060101345 AR053708A1 (en) 2006-04-05 2006-04-05 A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP060101345 AR053708A1 (en) 2006-04-05 2006-04-05 A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT

Publications (1)

Publication Number Publication Date
AR053708A1 true AR053708A1 (en) 2007-05-16

Family

ID=38048179

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101345 AR053708A1 (en) 2006-04-05 2006-04-05 A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT

Country Status (1)

Country Link
AR (1) AR053708A1 (en)

Similar Documents

Publication Publication Date Title
CL2012001950A1 (en) Use of a probiotic bacterial strain in the manufacture of a medicament or nutritional composition in humans or animals to alter sleep patterns
CO6440531A2 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
UY31484A1 (en) HETEROARIL-SUBSTITUTED PIPERIDINS
BRPI0917017B8 (en) s-nitrosoglutathione reductase pyrrole inhibitors as therapeutic agents
CR20110609A (en) ANTIMICROBIAL COMPOSITION AND RELATED METHODS OF USE
CL2008001855A1 (en) Boron-derived condensed cyclic compounds; pharmaceutical composition; and use in the treatment and / or prevention of an infectious disease.
CL2011003350A1 (en) Nitrogenous heterocycle derivative compounds, pkm2 modulators; pharmaceutical composition comprising them; and its use in the treatment of cancer.
CL2008000893A1 (en) Oral care composition comprising an effective amount of a basic amino acid and an antibacterial agent; use in the antibacterial treatment of the oral cavity.
GT200800250A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
ES2721898T3 (en) Stable formulations to lyophilize therapeutic particles
CL2013000018A1 (en) Compounds derived from indolizine, their preparation procedure; pharmaceutical composition; and use in the treatment of cancer, among others.
CO6300844A2 (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE
DOP2007000043A (en) SUBSTITUTED CHROMANOL DERIVATIVES AND THEIR USE
NI201000015A (en) BUPROPION BROMHYDRATE AND THERAPEUTIC APPLICATIONS
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
ECSP099807A (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
UY31717A1 (en) (PIRAZOLILCARBONIL) IMIDAZOLIDINONES REPLACED AND ITS USE
MX2011009277A (en) Activated leukocyte composition.
CL2008000707A1 (en) CONJUGATE OF ANTIFUSOGENIC POLYPEPTIDES AND POLYPEPTIDES DERIVED FROM THE GLOBULAR HEAD OF THE COMPLEMENT FACTOR C1Q; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; ITS USE TO TREAT VIRIC INFECTIONS; AND PRODUCTION METHOD.
AR053708A1 (en) A PHARMACEUTICAL COMPOSITION USED IN WOUND TREATMENT
AR082594A1 (en) PANTENYL DOCOSAHEXANOATE AND ITS USE FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
BRPI0802428A2 (en) use of oxides, and surface treatment composition

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee